ALKERMES reported 299.3M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Acadia Pharmaceuticals ACAD:US $ 173.33M 14.84M
Acorda Therapeutics ACOR:US $ 57.64M 58.91M
Amgen AMGN:US $ 3.77B 854M
Biogen BIIB:US $ 2289.3M 569.2M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 244M 29.31M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Coherus Biosciences CHRS:US $ 250.39M 156.4M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Gilead Sciences GILD:US $ 3971M 438M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
H. Lundbeck A/S LUN:DC 3.39B 680M
Heron Therapeutics HRTX:US $ 72.13M 9.77M
Horizon Pharma HZNP:US $ 502.42M 2.82M
Intra Cellular Therapies ITCI:US $ 69.1M 4.69M
JAZZ PHA JAZZ:US $ 445.46M 46.64M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Marinus Pharmaceuticals MRNS:US $ 28.97M 9.92M
Merk MRK:US $ 9905M 839M
Minerva Neurosciences NERV:US $ 7.51M 208.03K
Nektar Therapeutics NKTR:US $ 133.04M 1.14M
Neurocrine Biosciences NBIX:US $ 205.1M 10.6M
Otsuka Holdings 4578:JP Y 286697M 42283M
Pfizer PFE:US $ 13063M 3998M
Regeneron Pharmaceuticals REGN:US $ 1416M 160.1M
Revance Therapeutics RVNC:US $ 83.31M 5.79M
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Zogenix ZGNX:US $ 65.49M 10.79M